Staged Treatment in Early Psychosis: A sequential multiple assignment randomised trial of interventions for ultra high risk of psychosis patients

Barnaby Nelson, G. Paul Amminger, Hok Pan Yuen, Nicky Wallis, Melissa J. Kerr, Lisa Dixon, Cameron S Carter, Rachel Loewy, Tara A Niendam, Martha Shumway, Sarah Morris, Julie Blasioli, Patrick D. Mcgorry

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Aim: Previous research indicates that preventive intervention is likely to benefit patients "at risk" of psychosis, in terms of functional improvement, symptom reduction and delay or prevention of onset of threshold psychotic disorder. The primary aim of the current study is to test outcomes of ultra high risk (UHR) patients, primarily functional outcome, in response to a sequential intervention strategy consisting of support and problem solving (SPS), cognitive-behavioural case management and antidepressant medication. A secondary aim is to test biological and psychological variables that moderate and mediate response to this sequential treatment strategy. Methods: This is a sequential multiple assignment randomised trial (SMART) consisting of three steps: Step 1: SPS (1.5 months); Step 2: SPS vs Cognitive Behavioural Case Management (4.5 months); Step 3: Cognitive Behavioural Case Management+Antidepressant Medication vs Cognitive Behavioural Case Management+Placebo (6 months). The intervention is of 12 months duration in total and participants will be followed up at 18 months and 24 months post baseline. Conclusion: This paper reports on the rationale and protocol of the Staged Treatment in Early Psychosis (STEP) study. With a large sample of 500 UHR participants this study will investigate the most effective type and sequence of treatments for improving functioning and reducing the risk of developing psychotic disorder in this clinical population.

Original languageEnglish (US)
JournalEarly Intervention in Psychiatry
DOIs
StateAccepted/In press - 2017

Fingerprint

Case Management
Psychotic Disorders
Antidepressive Agents
Psychological Tests
Therapeutics
Clinical Protocols
Placebos
Research
Population

Keywords

  • Antidepressant medication
  • Clinical trial
  • Prodrome
  • Psychosis
  • Ultra high risk

ASJC Scopus subject areas

  • Phychiatric Mental Health
  • Psychiatry and Mental health
  • Biological Psychiatry

Cite this

Staged Treatment in Early Psychosis : A sequential multiple assignment randomised trial of interventions for ultra high risk of psychosis patients. / Nelson, Barnaby; Amminger, G. Paul; Yuen, Hok Pan; Wallis, Nicky; J. Kerr, Melissa; Dixon, Lisa; Carter, Cameron S; Loewy, Rachel; Niendam, Tara A; Shumway, Martha; Morris, Sarah; Blasioli, Julie; Mcgorry, Patrick D.

In: Early Intervention in Psychiatry, 2017.

Research output: Contribution to journalArticle

Nelson, Barnaby ; Amminger, G. Paul ; Yuen, Hok Pan ; Wallis, Nicky ; J. Kerr, Melissa ; Dixon, Lisa ; Carter, Cameron S ; Loewy, Rachel ; Niendam, Tara A ; Shumway, Martha ; Morris, Sarah ; Blasioli, Julie ; Mcgorry, Patrick D. / Staged Treatment in Early Psychosis : A sequential multiple assignment randomised trial of interventions for ultra high risk of psychosis patients. In: Early Intervention in Psychiatry. 2017.
@article{2d9064c7c473469fa26597a8f8fe4be7,
title = "Staged Treatment in Early Psychosis: A sequential multiple assignment randomised trial of interventions for ultra high risk of psychosis patients",
abstract = "Aim: Previous research indicates that preventive intervention is likely to benefit patients {"}at risk{"} of psychosis, in terms of functional improvement, symptom reduction and delay or prevention of onset of threshold psychotic disorder. The primary aim of the current study is to test outcomes of ultra high risk (UHR) patients, primarily functional outcome, in response to a sequential intervention strategy consisting of support and problem solving (SPS), cognitive-behavioural case management and antidepressant medication. A secondary aim is to test biological and psychological variables that moderate and mediate response to this sequential treatment strategy. Methods: This is a sequential multiple assignment randomised trial (SMART) consisting of three steps: Step 1: SPS (1.5 months); Step 2: SPS vs Cognitive Behavioural Case Management (4.5 months); Step 3: Cognitive Behavioural Case Management+Antidepressant Medication vs Cognitive Behavioural Case Management+Placebo (6 months). The intervention is of 12 months duration in total and participants will be followed up at 18 months and 24 months post baseline. Conclusion: This paper reports on the rationale and protocol of the Staged Treatment in Early Psychosis (STEP) study. With a large sample of 500 UHR participants this study will investigate the most effective type and sequence of treatments for improving functioning and reducing the risk of developing psychotic disorder in this clinical population.",
keywords = "Antidepressant medication, Clinical trial, Prodrome, Psychosis, Ultra high risk",
author = "Barnaby Nelson and Amminger, {G. Paul} and Yuen, {Hok Pan} and Nicky Wallis and {J. Kerr}, Melissa and Lisa Dixon and Carter, {Cameron S} and Rachel Loewy and Niendam, {Tara A} and Martha Shumway and Sarah Morris and Julie Blasioli and Mcgorry, {Patrick D.}",
year = "2017",
doi = "10.1111/eip.12459",
language = "English (US)",
journal = "Early Intervention in Psychiatry",
issn = "1751-7885",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Staged Treatment in Early Psychosis

T2 - A sequential multiple assignment randomised trial of interventions for ultra high risk of psychosis patients

AU - Nelson, Barnaby

AU - Amminger, G. Paul

AU - Yuen, Hok Pan

AU - Wallis, Nicky

AU - J. Kerr, Melissa

AU - Dixon, Lisa

AU - Carter, Cameron S

AU - Loewy, Rachel

AU - Niendam, Tara A

AU - Shumway, Martha

AU - Morris, Sarah

AU - Blasioli, Julie

AU - Mcgorry, Patrick D.

PY - 2017

Y1 - 2017

N2 - Aim: Previous research indicates that preventive intervention is likely to benefit patients "at risk" of psychosis, in terms of functional improvement, symptom reduction and delay or prevention of onset of threshold psychotic disorder. The primary aim of the current study is to test outcomes of ultra high risk (UHR) patients, primarily functional outcome, in response to a sequential intervention strategy consisting of support and problem solving (SPS), cognitive-behavioural case management and antidepressant medication. A secondary aim is to test biological and psychological variables that moderate and mediate response to this sequential treatment strategy. Methods: This is a sequential multiple assignment randomised trial (SMART) consisting of three steps: Step 1: SPS (1.5 months); Step 2: SPS vs Cognitive Behavioural Case Management (4.5 months); Step 3: Cognitive Behavioural Case Management+Antidepressant Medication vs Cognitive Behavioural Case Management+Placebo (6 months). The intervention is of 12 months duration in total and participants will be followed up at 18 months and 24 months post baseline. Conclusion: This paper reports on the rationale and protocol of the Staged Treatment in Early Psychosis (STEP) study. With a large sample of 500 UHR participants this study will investigate the most effective type and sequence of treatments for improving functioning and reducing the risk of developing psychotic disorder in this clinical population.

AB - Aim: Previous research indicates that preventive intervention is likely to benefit patients "at risk" of psychosis, in terms of functional improvement, symptom reduction and delay or prevention of onset of threshold psychotic disorder. The primary aim of the current study is to test outcomes of ultra high risk (UHR) patients, primarily functional outcome, in response to a sequential intervention strategy consisting of support and problem solving (SPS), cognitive-behavioural case management and antidepressant medication. A secondary aim is to test biological and psychological variables that moderate and mediate response to this sequential treatment strategy. Methods: This is a sequential multiple assignment randomised trial (SMART) consisting of three steps: Step 1: SPS (1.5 months); Step 2: SPS vs Cognitive Behavioural Case Management (4.5 months); Step 3: Cognitive Behavioural Case Management+Antidepressant Medication vs Cognitive Behavioural Case Management+Placebo (6 months). The intervention is of 12 months duration in total and participants will be followed up at 18 months and 24 months post baseline. Conclusion: This paper reports on the rationale and protocol of the Staged Treatment in Early Psychosis (STEP) study. With a large sample of 500 UHR participants this study will investigate the most effective type and sequence of treatments for improving functioning and reducing the risk of developing psychotic disorder in this clinical population.

KW - Antidepressant medication

KW - Clinical trial

KW - Prodrome

KW - Psychosis

KW - Ultra high risk

UR - http://www.scopus.com/inward/record.url?scp=85024932659&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85024932659&partnerID=8YFLogxK

U2 - 10.1111/eip.12459

DO - 10.1111/eip.12459

M3 - Article

C2 - 28719151

AN - SCOPUS:85024932659

JO - Early Intervention in Psychiatry

JF - Early Intervention in Psychiatry

SN - 1751-7885

ER -